Clinical Trials Logo

Neovascular Maculopathy clinical trials

View clinical trials related to Neovascular Maculopathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT00791570 Completed - Clinical trials for Age Related Macular Degeneration

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Start date: October 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and time to progression of HLA-A*2402 or A*0201 restricted epitope peptides VEGFR1 and VEGFR2 emulsified with Montanide ISA 51 in patients with Neovascular Maculopathy, including Age Related Macular Degeneration